查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2094782

血液透析及腹膜透析市場－2026-2032年全球市場預測

Hemodialysis & Peritoneal Dialysis Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，血液透析和腹膜透析市場將成長至 1,617.3 億美元，複合年成長率為 7.74%。

主要市場統計數據
基準年 2025 959.1億美元
預計年份：2026年 1025億美元
預測年份 2032 1617.3億美元
複合年成長率 (%) 7.74%

血液透析和腹膜透析仍然是腎衰竭患者的核心腎臟替代療法，其重要性日益凸顯，尤其是在慢性腎臟病與糖尿病、高血壓、心血管疾病、老齡化以及腎內科轉診延誤等因素的關聯日益密切的情況下。血液透析通常在醫療機構內進行，需要透析器、血管通路、水處理系統以及訓練有素的臨床團隊。而腹膜透析則允許患者在家中進行治療，透過腹膜和透析液交換、使用無菌耗材以及患者自我管理來實現。此領域的發展受到許多臨床因素的影響，例如透析的適用性、感染預防、體液管理、貧血管理、血管通路維護、殘餘腎功能以及生活品質。醫療保健系統也日益重視家庭透析、病患教育、遠端患者監護、可互通的電子健康記錄以及基於價值的腎臟護理，以減少不必要的住院治療，並改善透析前、透析、腎臟移植和安寧療護等各個環節的連續性。無論醫療保健系統是成熟還是新興，法律規範、報銷政策、人才引進和供應鏈韌性仍然是影響治療可及性和服務配置的關鍵因素。

透析方式的變革性變化

隨著醫療服務模式從以醫療機構為中心的治療轉向更靈活、以患者為中心的腎臟護理，透析的現狀正在經歷結構性變革。居家血液透析和腹膜透析正日益受到政策制定者的關注，因為透過適當的培訓和臨床隨訪，它們可以減輕患者就醫的負擔，支持個人化的治療方案，並提高患者的自主性。同時，對於合併多種複雜疾病的患者、居家支持有限的患者、需要緊急啟動治療的患者或有腹膜透析禁忌症的患者而言，醫療機構血液透析仍然至關重要。感染控制方案、生物相容性膜、高通量血液透析、血液透析濾過、自動化腹膜透析、導管設計、血管通路監測和水質標準等方面也出現了變化的跡象。腎臟護理和技術領域的人員短缺促使人們對自動化、標準化工作流程、遠端醫療支援和遠端故障排除產生了濃厚的興趣。此外，永續性是一項策略性考量，因為透析在水、能源、包裝材料和物流方面消耗大量資源。因此，醫療服務提供者和政策制定者在重新設計服務以應對日益嚴重的腎臟病負擔時，需要在臨床療效、經濟負擔、環境保護和公平獲取之間取得平衡。

人工智慧（AI）對透析護理的累積影響

人工智慧 (AI) 在血液透析和腹膜透析領域發揮著日益重要的作用，它能夠增強決策支援、風險分層、提高營運效率並提供個人化護理。在臨床實踐中，AI 驅動的分析技術，結合檢驗的臨床數據和臨床醫生的監督，有助於識別透析過程中低血壓、血管通路功能障礙、體液超負荷、住院、透析技術失敗和腹膜炎等高風險患者。在血液透析操作中，機器學習可以輔助最佳化治療方案、進行預測性維護、檢驗透析液和超過濾模式，以及早期發現治療異常。在腹膜透析中，連網的週期計和遠端監測平台能夠提供有關交換滲漏、引流問題、瀦留模式、超過濾趨勢和治療依從性的可操作資訊。當 AI 作為輔助層而非取代腎臟科醫師和透析護理師時，其累積效應最為顯著。 AI 的成功取決於資料品質、互通性、演算法透明度、網路安全、減少偏差、符合監管要求以及獲得患者知情同意。隨著腎臟護理領域數位化協作的進步，人工智慧可以改善透析中心、家庭透析計畫、檢查室、醫院和移植團隊之間的護理協調，而不會損害個人化臨床判斷的重要性。

全球透析市場的關鍵區域洞察

亞太地區是一個充滿活力的透析市場，其發展動力主要來自龐大的人口基數、糖尿病和高血壓患病率的上升、不斷擴大的醫療基礎設施以及政府為改善都市區腎臟護理服務所做的努力。中國、印度、日本、韓國和澳洲等國家存在著不同的透析模式。日本和韓國擁有先進的院內血液透析系統，澳洲支持居家透析，而中國和印度正在擴大透析能力，同時努力解決經濟負擔和地理差異問題。北美地區的特點是擁有完善的報銷體系、廣泛的透析診所網路、對居家透析的日益重視以及主導改善腎臟護理協調的政策舉措，尤其是在美國和加拿大。在拉丁美洲，公立和私立醫療系統的透析服務水準參差不齊，巴西和墨西哥是主要的透析中心，但農村地區的透析服務、腎臟移植機會以及自付費用仍然是重大挑戰。在歐洲，腎臟病治療具有許多優勢，例如完善的臨床指南、國家腎臟登記系統、成熟的腎臟病學會以及人們對居家護理日益成長的興趣。然而，由於報銷體系、病患教育和醫療服務基礎設施的差異，各國腎臟病治療的普及程度不盡相同。在中東，透過對公立醫院和專科中心的投資，腎臟病治療基礎設施正在不斷完善；海灣合作理事會（GCC）國家則致力於先進技術和慢性病防治計畫；而受衝突影響的地區則面臨著醫療服務連續性的風險。在非洲，由於腎臟專科醫生短缺、經濟拮据、基礎設施不平衡以及診斷延遲等問題，腎臟病治療仍然面臨著許多障礙，因此，預防、早期發現和永續透析是該地區亟需解決的關鍵問題。

東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約的關鍵集團分析

在東南亞國協，儘管糖尿病相關腎臟病、都市區差距以及保險報銷差異等問題依然存在，但透析服務的普及率正在不斷提高。新加坡、馬來西亞和泰國正在製定更系統化的腎臟護理計劃，而其他市場則繼續獲得公共資金支持並加強臨床能力建設。在海灣合作理事會（GCC）國家，非傳染性疾病的高發生率以及優先考慮慢性病管理的國家衛生改革計劃，推動了對先進醫院基礎設施、透析中心擴建和專業人員培訓的投資。歐盟受益於統一的醫療設備法規、跨境臨床合作、成熟的腎臟登記系統和腎臟護理指南，但成員國在居家透析普及率、採購模式和保險報銷獎勵方面存在差異。金磚國家整體呈現透析服務現況的多樣性。中國和印度面臨龐大的病患群體和不斷成長的治療能力需求；巴西擁有大規模的公共透析系統；俄羅斯在廣闊的地區維持著與醫院相連的腎臟醫療保健服務；而南非則反映了非洲通用的挑戰，例如經濟負擔和醫療服務取得方面的不平等。儘管七國集團（G7）國家普遍擁有先進的腎臟醫療保健系統、完善的法律規範機制、腎臟登記系統以及較高的品質標準採納率，但它們仍然面臨著人口老齡化、勞動力短缺以及在臨床適宜的情況下擴大居家護理服務的需求。北約成員國的腎臟醫療保健系統與北美和高所得歐洲國家的腎臟醫療保健系統高度重疊，因此，對於必須在公共衛生危機、自然災害或地緣政治動盪期間不間斷運行的透析服務而言，韌性規劃、供應鏈連續性、聯網設備的網路安全以及應急準備變得日益重要。

主要國家血液透析和腹膜透析的發展趨勢

美國擁有世界上最發達的透析基礎設施之一，這得益於聯邦政府對腎衰竭治療的醫保覆蓋、大規模的院內透析網路以及旨在促進居家透析和移植導向型護理協調的政策舉措。加拿大強調全民健保、省級腎臟病計畫、居家照護教育和品質改進，但偏遠地區和原住民社區的透析服務取得並不均衡。墨西哥在糖尿病高發生且公私健康照護體系混合的情況下，正努力擴大透析服務的可近性。同時，巴西擁有拉丁美洲最重要的透析系統之一，並持續致力於解決區域不平等和移植過渡路徑上的障礙。英國透過其國家醫療服務系統、品質註冊系統和居家透析推廣來支援腎臟醫療保健服務，而德國則擁有強大的專科醫療體系、先進的血液透析基礎設施和高度的臨床標準化。法國將健全的健保報銷體系與完善的腎臟病網路和以病人為中心的治療方案結合。另一方面，俄羅斯則在人口地域分散和區域基礎設施差異的情況下，努力保障透析服務的可及性。義大利和西班牙擁有成熟的透析項目，並與腎臟移植緊密結合，日益重視居家照護、老年患者以及多種合併症的管理。中國正透過醫院網路和醫療政策改革來擴大透析能力，而印度則面臨著未滿足需求的嚴重性、經濟負擔的壓力以及部分地區需要加強公共衛生支持的困境。日本以其高品質的血液透析實踐、長期患者生存記錄和嚴格的治療標準而聞名，但居家透析的普及率仍然相對較低。澳洲擁有健全的居家透析體系，並獲得腎臟網路和遠距醫療模式的支持。另一方面，韓國則結合了先進的醫院透析能力、數位醫療應對力以及較高的慢性病負擔，這些都支撐著對綜合腎臟護理的需求。

為透析行業領導者提供的實用建議

產業領導者應優先考慮治療中立的腎臟照護路徑，幫助患者在院內血液透析、居家血液透析、腹膜透析、腎臟移植以及適當的保守治療等多種治療方案中做出明智的選擇。增加對病患教育、看護者支援、多語言訓練資料以及早期轉診至腎臟科的投入，可以提高病患的治療準備度，並減少緊急透析的啟動。醫療服務提供者應加強感染預防、血管通路規劃、腹膜炎預防項目以及標準化品質指標，並將遠端監測和遠距遠端醫療整合到居家透析操作中。製造商和服務機構應專注於透析器、濃縮液、輸液、導管和耗材的易用性、自動化、網路安全、互通性、水和能源效率以及彈性供應鏈。政策制定者和保險公司可以透過將報銷與治療結果掛鉤、支持居家透析基礎設施建設、資助人力資源開發以及減少低收入和農村患者的經濟障礙來改善透析服務的可及性。此外，領導者應制定緊急應變方案，以確保即使在災難、流行病、停電、物流中斷或網路安全事件的情況下，透析也能繼續進行。

透析產業分析的調查方法

本研究方法結合了檢驗的二手資訊、臨床指南、監管文件、腎臟病登記出版刊物、同行評審的腎臟病學文獻、公共衛生資料集、報銷政策以及專家對各種醫療服務模式的解讀。資訊來源的評估標準包括可靠性、時效性、地理相關性、方法透明度以及多篇參考文獻的一致性。血液透析和腹膜透析的分析考慮了臨床結果、治療可及性、報銷機制設計、基礎設施建設、醫療設備監管、醫療服務提供者人員配備、患者體驗、數位醫療應用以及醫療公平性。區域、群體和國家層面的見解均透過公共衛生機構出版刊物、腎臟病登記處、國際腎臟病學會和醫療設備法規結構進行檢驗。本調查方法避免了毫無根據的預測，並清楚地區分了觀察到的趨勢、政策趨勢、臨床證據和營運影響。透過將定量醫學指標與定性專家解讀相結合，本研究對透析可及性、創新和醫療轉型提供了平衡的視角。

結論：推廣以病人為中心的透析護理

血液透析和腹膜透析在腎衰竭的治療中發揮核心作用，並透過居家照護、數位化監測、人工智慧分析、改進的醫療設備設計以及更嚴格的品質標準不斷發展。該行業最重要的議題不僅限於治療能力，還包括公平獲取醫療服務、病人自主權、感染預防、醫護人員的韌性、保險報銷的一致性、永續性和照護的連續性。區域差異依然顯著，高所得國家的醫療體系專注於最佳化和擴大家庭護理，而新興市場則優先考慮可負擔性、基礎設施建設和早期診斷。人工智慧和互聯醫療技術，如果能在強力的管治和臨床課責制下實施，可以提高透析的安全性和個人化程度。那些將實證臨床實踐、韌性管理、以患者為中心的教育和負責任的創新相結合的機構，將更有能力支持更安全、更永續的腎臟護理。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 血液透析與腹膜透析市場：依治療類型分類

  • 血液透析
  • 腹膜透析
    • 自動化腹膜透析
    • 持續性攜帶式腹膜透析

第8章 血液透析與腹膜透析市場：依透析方式分類

  • 家
    • 護理支持
    • 自我護理
  • 設施內部

第9章 血液透析及腹膜透析市場：依技術分類

  • 傳統血液透析
  • 線上血液透析過濾
    • 混合流法
    • 置換流

第10章 血液透析與腹膜透析市場：依產品類型分類

  • 濃縮液/輸液
  • 透析機
  • 透析機
    • 高通量
    • 低通量
  • 監控系統
  • 管組

第11章 血液透析與腹膜透析市場：依病患類型分類

  • 成人
  • 老年人
  • 兒童

第12章 血液透析和腹膜透析市場：依最終用戶分類

  • 透析中心
  • 居家醫療
  • 醫院
  • 專科診所

第13章 血液透析與腹膜透析市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章 血液透析與腹膜透析市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 血液透析和腹膜透析市場：按國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Allmed Medical Products Co., Ltd.
  • AngioDynamics, Inc.
  • Asahi Kasei Corporation
  • B. Braun SE
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • DaVita Inc.
  • Dialife SA
  • Diaverum AB
  • Evoqua Water Technologies LLC
  • Fresenius Medical Care AG & Co. KGaA
  • Hemoclean Co. Ltd.
  • Jafron Biomedical Co., Ltd.
  • JMS Co., Ltd.
  • Medica SpA
  • Medtronic PLC
  • Nikkiso Co., Ltd.
  • Nipro Corporation
  • NxStage Medical Inc.
  • Rajsun Innovations LLP
  • Rockwell Medical Inc.
  • SB-KAWASUMI LABORATORIES, INC.
  • STERIS Group
  • Toray Medical Co., Ltd.
  • Trivitron Healthcare
Product Code: MRR-8201ABF21C57

The Hemodialysis & Peritoneal Dialysis Market is projected to grow by USD 161.73 billion at a CAGR of 7.74% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 95.91 billion
Estimated Year [2026] USD 102.50 billion
Forecast Year [2032] USD 161.73 billion
CAGR (%) 7.74%

Hemodialysis and peritoneal dialysis remain core renal replacement therapies for people living with kidney failure, particularly as chronic kidney disease is increasingly linked to diabetes, hypertension, cardiovascular disease, aging populations, and delayed nephrology referral. Hemodialysis is commonly delivered through in-center care models using dialyzers, vascular access, water treatment systems, and trained clinical teams, while peritoneal dialysis enables home-based treatment through the peritoneal membrane, dialysate exchanges, sterile consumables, and patient self-management. The sector is shaped by clinical priorities such as dialysis adequacy, infection prevention, fluid management, anemia control, vascular access preservation, residual kidney function, and quality of life. Health systems are also placing greater emphasis on home dialysis adoption, patient education, remote patient monitoring, interoperable electronic health records, and value-based kidney care to reduce avoidable hospitalizations and improve continuity across pre-dialysis, dialysis, transplant, and palliative pathways. Regulatory oversight, reimbursement policy, workforce availability, and supply chain resilience remain decisive factors influencing treatment access and service configuration across mature and emerging healthcare systems.

Transformative Shifts in the Dialysis Landscape

The dialysis landscape is undergoing structural change as care delivery shifts from facility-centered treatment toward more flexible, patient-centered kidney care. Home hemodialysis and peritoneal dialysis are gaining policy attention because they can reduce travel burden, support individualized schedules, and improve autonomy when patients receive appropriate training and clinical follow-up. At the same time, in-center hemodialysis continues to be essential for patients with complex comorbidities, limited home support, urgent-start requirements, or contraindications to peritoneal dialysis. Transformation is also visible in infection control protocols, biocompatible membranes, high-flux hemodialysis, hemodiafiltration approaches, automated peritoneal dialysis, catheter design, vascular access surveillance, and water quality standards. Workforce shortages in nephrology nursing and technician roles are accelerating interest in automation, standardized workflows, telehealth-enabled support, and remote troubleshooting. Sustainability has also become a strategic consideration, as dialysis is resource-intensive in water, energy, packaging, and logistics. Providers and policymakers are therefore balancing clinical outcomes, affordability, environmental stewardship, and equitable access while redesigning services for a rising kidney disease burden.

Cumulative Impact of Artificial Intelligence on Dialysis Care

Artificial intelligence is becoming increasingly relevant across hemodialysis and peritoneal dialysis by strengthening decision support, risk stratification, operational efficiency, and personalized care. In clinical settings, AI-enabled analytics can help identify patients at elevated risk of intradialytic hypotension, vascular access dysfunction, fluid overload, hospitalization, technique failure, and peritonitis when integrated with validated clinical data and clinician oversight. For hemodialysis operations, machine learning can support scheduling optimization, predictive maintenance, dialysate and ultrafiltration pattern review, and early detection of treatment anomalies. In peritoneal dialysis, connected cyclers and remote monitoring platforms can generate actionable insights on missed exchanges, drain issues, dwell patterns, ultrafiltration trends, and adherence signals. The cumulative impact of AI is strongest when deployed as an assistive layer rather than a replacement for nephrologists and dialysis nurses. Its success depends on data quality, interoperability, algorithm transparency, cybersecurity, bias mitigation, regulatory compliance, and patient consent. As kidney care becomes more digitally connected, AI can improve care coordination between dialysis centers, home programs, laboratories, hospitals, and transplant teams without diminishing the importance of individualized clinical judgment.

Key Regional Insights Across Global Dialysis Markets

Asia-Pacific is a highly dynamic dialysis region because of large populations, rising diabetes and hypertension prevalence, expanding healthcare infrastructure, and government efforts to improve kidney care access in urban and secondary cities. Countries such as China, India, Japan, South Korea, and Australia show different dialysis models, with Japan and South Korea maintaining advanced in-center hemodialysis capabilities, Australia supporting home dialysis pathways, and China and India expanding capacity while addressing affordability and geographic disparities. North America is characterized by established reimbursement structures, broad dialysis clinic networks, growing emphasis on home dialysis, and policy-driven efforts to improve kidney care coordination, particularly in the United States and Canada. Latin America faces uneven access across public and private systems, with Brazil and Mexico serving as major dialysis hubs while rural access, transplant availability, and out-of-pocket costs remain critical challenges. Europe benefits from strong clinical guidelines, national renal registries, established nephrology societies, and increasing interest in home therapies, though uptake varies by country depending on reimbursement, patient education, and workforce capacity. The Middle East is expanding renal care infrastructure through public hospital investment and specialty centers, with GCC countries focusing on advanced technologies and chronic disease programs, while conflict-affected areas face continuity-of-care risks. Africa continues to experience significant access barriers due to limited nephrology workforce, affordability constraints, infrastructure gaps, and late diagnosis, making prevention, early detection, and sustainable dialysis delivery essential regional priorities.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN countries are expanding dialysis access against a backdrop of diabetes-driven kidney disease, urban-rural disparities, and variable reimbursement coverage, with Singapore, Malaysia, and Thailand showing more structured kidney care programs while other markets continue to strengthen public financing and clinical capacity. The GCC is investing in advanced hospital infrastructure, dialysis center expansion, and specialist workforce development, supported by high noncommunicable disease prevalence and national health transformation programs that prioritize chronic disease management. The European Union benefits from harmonized medical device regulation, cross-border clinical collaboration, mature renal registries, and kidney care guidelines, while individual member states differ in home dialysis penetration, procurement models, and reimbursement incentives. BRICS countries collectively represent diverse dialysis realities: China and India face large patient populations and capacity expansion needs, Brazil has a significant publicly supported dialysis system, Russia maintains hospital-linked renal services across a vast geography, and South Africa reflects broader African challenges around affordability and unequal access. G7 countries generally have advanced nephrology systems, established regulatory oversight, renal registries, and high adoption of quality standards, yet they continue to confront aging populations, workforce shortages, and the need to expand home-based therapy where clinically appropriate. NATO member countries overlap significantly with high-income renal care systems in North America and Europe, where resilience planning, supply chain continuity, cybersecurity for connected devices, and emergency preparedness are increasingly important for dialysis services that must operate without interruption during public health crises, natural disasters, or geopolitical disruptions.

Key Country Insights in Hemodialysis and Peritoneal Dialysis

The United States has one of the most developed dialysis infrastructures, supported by federal coverage for kidney failure care, a large in-center network, and policy initiatives encouraging home dialysis and transplant-oriented care coordination. Canada emphasizes universal health coverage, provincial kidney programs, home therapy education, and quality improvement, though access can vary across remote and Indigenous communities. Mexico is working to expand access amid a high burden of diabetes and mixed public-private coverage, while Brazil operates one of Latin America's most significant dialysis systems and continues to address regional inequities and transplant pathway constraints. The United Kingdom supports renal services through national health structures, quality registries, and home dialysis promotion, while Germany maintains strong specialist capacity, advanced hemodialysis infrastructure, and high clinical standardization. France combines robust reimbursement with established nephrology networks and patient-centered modality planning, whereas Russia manages dialysis access across a geographically dispersed population with regional differences in infrastructure. Italy and Spain maintain mature dialysis programs, strong transplant integration, and growing attention to home therapies, aging patients, and multimorbidity management. China is expanding dialysis capacity through hospital networks and health policy reforms, while India faces substantial unmet need, affordability pressures, and expanding public insurance support in several states. Japan is recognized for high-quality hemodialysis practices, long patient survival experience, and rigorous treatment standards, although home dialysis uptake remains comparatively limited. Australia has a strong home dialysis culture supported by renal networks and remote-care models, while South Korea combines advanced hospital-based dialysis capacity, digital health readiness, and a high chronic disease burden that sustains demand for comprehensive kidney care.

Actionable Recommendations for Dialysis Industry Leaders

Industry leaders should prioritize modality-neutral kidney care pathways that help patients make informed choices among in-center hemodialysis, home hemodialysis, peritoneal dialysis, transplantation, and conservative care where appropriate. Investment in patient education, caregiver support, multilingual training materials, and early nephrology referral can improve therapy preparedness and reduce urgent dialysis starts. Providers should strengthen infection prevention, vascular access planning, peritonitis reduction programs, and standardized quality metrics while embedding remote monitoring and telehealth into home dialysis operations. Manufacturers and service organizations should focus on device usability, automation, cybersecurity, interoperability, water and energy efficiency, and resilient supply chains for dialyzers, concentrates, fluids, catheters, and consumables. Policymakers and payers can improve access by aligning reimbursement with outcomes, supporting home therapy infrastructure, funding workforce development, and reducing financial barriers for low-income and rural patients. Leaders should also build emergency preparedness protocols for dialysis continuity during disasters, pandemics, power interruptions, logistics disruptions, and cybersecurity incidents.

Research Methodology for Dialysis Industry Analysis

The research approach combines validated secondary sources, clinical guidelines, regulatory documents, renal registry publications, peer-reviewed nephrology literature, public health datasets, reimbursement policies, and expert interpretation across care delivery models. Evidence is assessed for source credibility, recency, geographic relevance, methodological transparency, and consistency across multiple references. Analysis of hemodialysis and peritoneal dialysis considers clinical outcomes, modality access, reimbursement design, infrastructure readiness, device regulation, workforce capacity, patient experience, digital health adoption, and health equity. Regional, group, and country-level insights are cross-checked against official health authority publications, kidney disease registries, international nephrology organizations, and medical device regulatory frameworks. The methodology avoids unsupported projections and distinguishes clearly between observed trends, policy developments, clinical evidence, and operational implications. Triangulation across quantitative healthcare indicators and qualitative expert interpretation provides a balanced view of dialysis access, innovation, and care transformation.

Conclusion: Advancing Patient-Centered Dialysis Care

Hemodialysis and peritoneal dialysis are central to kidney failure management and are evolving through home-based care, digital monitoring, AI-enabled analytics, improved device design, and stronger quality standards. The most important industry themes extend beyond treatment capacity to include equitable access, patient autonomy, infection prevention, workforce resilience, reimbursement alignment, sustainability, and continuity of care. Regional differences remain substantial, with high-income systems focusing on optimization and home therapy expansion, while emerging markets prioritize affordability, infrastructure, and earlier diagnosis. AI and connected care technologies can improve dialysis safety and personalization when implemented with strong governance and clinical accountability. Organizations that combine evidence-based clinical practice, resilient operations, patient-centered education, and responsible innovation will be best positioned to support safer, more accessible, and more sustainable kidney care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Hemodialysis & Peritoneal Dialysis Market, by Treatment Type

  • 7.1. Introduction
  • 7.2. Hemodialysis
  • 7.3. Peritoneal Dialysis
    • 7.3.1. Automated Peritoneal
    • 7.3.2. Continuous Ambulatory Peritoneal

8. Hemodialysis & Peritoneal Dialysis Market, by Modality

  • 8.1. Introduction
  • 8.2. Home
    • 8.2.1. Assisted Care
    • 8.2.2. Self Care
  • 8.3. In Center

9. Hemodialysis & Peritoneal Dialysis Market, by Technology

  • 9.1. Introduction
  • 9.2. Conventional Hemodialysis
  • 9.3. Online Hemodiafiltration
    • 9.3.1. Mixed Flow
    • 9.3.2. Substitution Flow

10. Hemodialysis & Peritoneal Dialysis Market, by Product Type

  • 10.1. Introduction
  • 10.2. Concentrates Fluids
  • 10.3. Dialysis Machines
  • 10.4. Dialyzers
    • 10.4.1. High Flux
    • 10.4.2. Low Flux
  • 10.5. Monitoring Systems
  • 10.6. Tubing Sets

11. Hemodialysis & Peritoneal Dialysis Market, by Patient Type

  • 11.1. Introduction
  • 11.2. Adult
  • 11.3. Geriatric
  • 11.4. Pediatric

12. Hemodialysis & Peritoneal Dialysis Market, by End User

  • 12.1. Introduction
  • 12.2. Dialysis Centers
  • 12.3. Home Care Settings
  • 12.4. Hospitals
  • 12.5. Specialty Clinics

13. Hemodialysis & Peritoneal Dialysis Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Hemodialysis & Peritoneal Dialysis Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Hemodialysis & Peritoneal Dialysis Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2025
  • 16.2. FPNV Positioning Matrix, 2025
  • 16.3. Market Concentration Analysis, 2025
    • 16.3.1. Concentration Ratio (CR)
    • 16.3.2. Herfindahl Hirschman Index (HHI)
  • 16.4. Recent Developments & Impact Analysis, 2025
  • 16.5. Product Portfolio Analysis, 2025
  • 16.6. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Allmed Medical Products Co., Ltd.
  • 17.2. AngioDynamics, Inc.
  • 17.3. Asahi Kasei Corporation
  • 17.4. B. Braun SE
  • 17.5. Baxter International, Inc.
  • 17.6. Becton, Dickinson and Company
  • 17.7. DaVita Inc.
  • 17.8. Dialife SA
  • 17.9. Diaverum AB
  • 17.10. Evoqua Water Technologies LLC
  • 17.11. Fresenius Medical Care AG & Co. KGaA
  • 17.12. Hemoclean Co. Ltd.
  • 17.13. Jafron Biomedical Co., Ltd.
  • 17.14. JMS Co., Ltd.
  • 17.15. Medica S.p.A.
  • 17.16. Medtronic PLC
  • 17.17. Nikkiso Co., Ltd.
  • 17.18. Nipro Corporation
  • 17.19. NxStage Medical Inc.
  • 17.20. Rajsun Innovations LLP
  • 17.21. Rockwell Medical Inc.
  • 17.22. SB-KAWASUMI LABORATORIES, INC.
  • 17.23. STERIS Group
  • 17.24. Toray Medical Co., Ltd.
  • 17.25. Trivitron Healthcare

LIST OF FIGURES

  • FIGURE 1. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 25. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HEMODIALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HEMODIALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HEMODIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL AUTOMATED PERITONEAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL AUTOMATED PERITONEAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL AUTOMATED PERITONEAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CONTINUOUS AMBULATORY PERITONEAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CONTINUOUS AMBULATORY PERITONEAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CONTINUOUS AMBULATORY PERITONEAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HOME MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HOME MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HOME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ASSISTED CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ASSISTED CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ASSISTED CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SELF CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SELF CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SELF CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL IN CENTER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL IN CENTER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL IN CENTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CONVENTIONAL HEMODIALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CONVENTIONAL HEMODIALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CONVENTIONAL HEMODIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ONLINE HEMODIAFILTRATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ONLINE HEMODIAFILTRATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ONLINE HEMODIAFILTRATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MIXED FLOW MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MIXED FLOW MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MIXED FLOW MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SUBSTITUTION FLOW MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SUBSTITUTION FLOW MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SUBSTITUTION FLOW MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CONCENTRATES FLUIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CONCENTRATES FLUIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CONCENTRATES FLUIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DIALYSIS MACHINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DIALYSIS MACHINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DIALYSIS MACHINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DIALYZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DIALYZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DIALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HIGH FLUX MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HIGH FLUX MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HIGH FLUX MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL LOW FLUX MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL LOW FLUX MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL LOW FLUX MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MONITORING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MONITORING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL TUBING SETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL TUBING SETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL TUBING SETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL DIALYSIS CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL DIALYSIS CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL DIALYSIS CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. GCC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 167. GCC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. GCC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 169. GCC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 170. GCC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 171. GCC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 172. GCC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 173. GCC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. GCC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 175. GCC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. GCC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. G7 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 200. G7 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. G7 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 202. G7 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 203. G7 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 204. G7 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 205. G7 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 206. G7 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. G7 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 208. G7 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. G7 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. NATO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 211. NATO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. NATO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 213. NATO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 214. NATO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 215. NATO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 216. NATO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 217. NATO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. NATO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 219. NATO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. NATO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. CANADA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 234. CANADA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. CANADA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 236. CANADA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 237. CANADA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 238. CANADA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 239. CANADA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 240. CANADA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. CANADA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 242. CANADA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. CANADA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. MEXICO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 245. MEXICO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. MEXICO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 247. MEXICO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 248. MEXICO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 249. MEXICO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 250. MEXICO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 251. MEXICO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. MEXICO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 253. MEXICO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. MEXICO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. BRAZIL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 256. BRAZIL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. BRAZIL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 258. BRAZIL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 259. BRAZIL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 260. BRAZIL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 261. BRAZIL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 262. BRAZIL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. BRAZIL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 264. BRAZIL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. BRAZIL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED KINGDOM HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED KINGDOM HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED KINGDOM HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED KINGDOM HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED KINGDOM HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED KINGDOM HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED KINGDOM HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED KINGDOM HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED KINGDOM HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED KINGDOM HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED KINGDOM HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 277. GERMANY HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 278. GERMANY HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. GERMANY HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 280. GERMANY HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 281. GERMANY HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 282. GERMANY HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 283. GERMANY HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 284. GERMANY HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. GERMANY HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 286. GERMANY HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. GERMANY HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 288. FRANCE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 289. FRANCE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 290. FRANCE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 291. FRANCE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 292. FRANCE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 293. FRANCE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 294. FRANCE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 295. FRANCE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 296. FRANCE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 297. FRANCE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. FRANCE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 299. RUSSIA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 300. RUSSIA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 301. RUSSIA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 302. RUSSIA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 303. RUSSIA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 304. RUSSIA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 305. RUSSIA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 306. RUSSIA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 307. RUSSIA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 308. RUSSIA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 309. RUSSIA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 310. ITALY HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 311. ITALY HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 312. ITALY HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 313. ITALY HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 314. ITALY HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 315. ITALY HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 316. ITALY HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 317. ITALY HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 318. ITALY HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 319. ITALY HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 320. ITALY HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 321. SPAIN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 322. SPAIN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 323. SPAIN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 324. SPAIN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 325. SPAIN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2032 (USD MILLION)
  • TABLE 326. SPAIN HEMODIALYSIS